🔎 Trials Near Me

Dachaigh › Dermatomyositis › North Carolina

Sgrùdaidhean clionaigeach Dermatomyositis ann an North Carolina

Tha 8 sgrùdaidhean airson Dermatomyositis a’ lorg phàirtichean aig làraichean ann an North Carolina.

Bailtean ann an North Carolina

Teacsa sgrùdaidh oifigeil (Beurla)

Environmental Risk Factors for the Anti-synthetase Syndrome

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01276470

Adult and Juvenile Myositis

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT00017914

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
  • Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
A’ fastadhÌre 2/3
Aoisean 6 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Atrium Health Rheumatology-Southpark, Charlotte
  • Duke University Medical Center, Durham
A’ fastadhÌre 1
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • Universtity of North Carolina at Chapel Hill, Chapel Hill
A’ fastadhÌre 1
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06371417

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Duke University, Durham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07115745

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.